Home > > > > Report Detail

Global Antibody Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 15-Sep-2022
No. of pages: 128
Inquire Before Buying

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called "antigens"). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler - scientists at the Roche-funded Basel Institute for Immunology - who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Antibody market is projected to reach US$ 13110 million by 2028 from an estimated US$ 9613.8 million in 2022, at a CAGR of 5.3% during 2023 and 2028.

Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.

In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Antibody.

The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Roche

- Johnson and Johnson

- Merck

- Novartis

- AbbVie

- Amgen

- Pfizer

- Bayer

- Lilly

- Bristol-Myers Squibb

- GlaxoSmithKline

- Biogen

- AstraZeneca

- Sanofi

- Alexion Pharmaceuticals

- Seattle Genetics

Product Type Insights

Global markets are presented by Antibody type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Antibody are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Antibody Segment by Type

- IgM

- IgG

- IgA

- Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Antibody market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antibody market.

Antibody Segment by Application

- Therapeutic

- Research

- Diagnostic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Antibody market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antibody industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Antibody Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Antibody Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Market by Application
1.3.1 Global Antibody Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody Market Size Estimates and Forecasts
2.1.1 Global Antibody Revenue 2017-2028
2.1.2 Global Antibody Sales 2017-2028
2.2 Antibody Market Size by Region: 2022 Versus 2028
2.3 Antibody Sales by Region (2017-2028)
2.3.1 Global Antibody Sales by Region: 2017-2022
2.3.2 Global Antibody Sales Forecast by Region (2023-2028)
2.3.3 Global Antibody Sales Market Share by Region (2017-2028)
2.4 Antibody Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Antibody Revenue by Region: 2017-2022
2.4.2 Global Antibody Revenue Forecast by Region (2023-2028)
2.4.3 Global Antibody Revenue Market Share by Region (2017-2028)
3 Global Antibody by Manufacturers
3.1 Global Top Antibody Manufacturers by Sales
3.1.1 Global Antibody Sales by Manufacturer (2017-2022)
3.1.2 Global Antibody Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Antibody Manufacturers by Revenue
3.2.1 Global Antibody Revenue by Manufacturer (2017-2022)
3.2.2 Global Antibody Revenue Share by Manufacturer (2017-2022)
3.3 Global Antibody Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Antibody Manufacturers Covered: Ranking by Revenue
3.4.2 Global Antibody Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Antibody Manufacturing Base Distribution, Product Type
3.5.1 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Antibody Product Type
3.5.3 Date of International Manufacturers Enter into Antibody Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Corporation Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Antibody Products Offered
4.1.4 Roche Antibody Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Roche Antibody Sales by Product in 2021
4.1.6 Roche Antibody Sales by Application in 2021
4.1.7 Roche Antibody Sales by Geographic Area in 2021
4.1.8 Roche Recent Developments
4.2 Johnson and Johnson
4.2.1 Johnson and Johnson Corporation Information
4.2.2 Johnson and Johnson Description, Business Overview
4.2.3 Johnson and Johnson Antibody Products Offered
4.2.4 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Johnson and Johnson Antibody Sales by Product in 2021
4.2.6 Johnson and Johnson Antibody Sales by Application in 2021
4.2.7 Johnson and Johnson Antibody Sales by Geographic Area in 2021
4.2.8 Johnson and Johnson Recent Developments
4.3 Merck
4.3.1 Merck Corporation Information
4.3.2 Merck Description, Business Overview
4.3.3 Merck Antibody Products Offered
4.3.4 Merck Antibody Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Merck Antibody Sales by Product in 2021
4.3.6 Merck Antibody Sales by Application in 2021
4.3.7 Merck Antibody Sales by Geographic Area in 2021
4.3.8 Merck Recent Developments
4.4 Novartis
4.4.1 Novartis Corporation Information
4.4.2 Novartis Description, Business Overview
4.4.3 Novartis Antibody Products Offered
4.4.4 Novartis Antibody Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Novartis Antibody Sales by Product in 2021
4.4.6 Novartis Antibody Sales by Application in 2021
4.4.7 Novartis Antibody Sales by Geographic Area in 2021
4.4.8 Novartis Recent Developments
4.5 AbbVie
4.5.1 AbbVie Corporation Information
4.5.2 AbbVie Description, Business Overview
4.5.3 AbbVie Antibody Products Offered
4.5.4 AbbVie Antibody Sales, Revenue and Gross Margin (2017-2022)
4.5.5 AbbVie Antibody Sales by Product in 2021
4.5.6 AbbVie Antibody Sales by Application in 2021
4.5.7 AbbVie Antibody Sales by Geographic Area in 2021
4.5.8 AbbVie Recent Developments
4.6 Amgen
4.6.1 Amgen Corporation Information
4.6.2 Amgen Description, Business Overview
4.6.3 Amgen Antibody Products Offered
4.6.4 Amgen Antibody Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Amgen Antibody Sales by Product in 2021
4.6.6 Amgen Antibody Sales by Application in 2021
4.6.7 Amgen Antibody Sales by Geographic Area in 2021
4.6.8 Amgen Recent Development
4.7 Pfizer
4.7.1 Pfizer Corporation Information
4.7.2 Pfizer Description, Business Overview
4.7.3 Pfizer Antibody Products Offered
4.7.4 Pfizer Antibody Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Pfizer Antibody Sales by Product in 2021
4.7.6 Pfizer Antibody Sales by Application in 2021
4.7.7 Pfizer Antibody Sales by Geographic Area in 2021
4.7.8 Pfizer Recent Development
4.8 Bayer
4.8.1 Bayer Corporation Information
4.8.2 Bayer Description, Business Overview
4.8.3 Bayer Antibody Products Offered
4.8.4 Bayer Antibody Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Bayer Antibody Sales by Product in 2021
4.8.6 Bayer Antibody Sales by Application in 2021
4.8.7 Bayer Antibody Sales by Geographic Area in 2021
4.8.8 Bayer Recent Development
4.9 Lilly
4.9.1 Lilly Corporation Information
4.9.2 Lilly Description, Business Overview
4.9.3 Lilly Antibody Products Offered
4.9.4 Lilly Antibody Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Lilly Antibody Sales by Product in 2021
4.9.6 Lilly Antibody Sales by Application in 2021
4.9.7 Lilly Antibody Sales by Geographic Area in 2021
4.9.8 Lilly Recent Development
4.10 Bristol-Myers Squibb
4.10.1 Bristol-Myers Squibb Corporation Information
4.10.2 Bristol-Myers Squibb Description, Business Overview
4.10.3 Bristol-Myers Squibb Antibody Products Offered
4.10.4 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Bristol-Myers Squibb Antibody Sales by Product in 2021
4.10.6 Bristol-Myers Squibb Antibody Sales by Application in 2021
4.10.7 Bristol-Myers Squibb Antibody Sales by Geographic Area in 2021
4.10.8 Bristol-Myers Squibb Recent Development
4.11 GlaxoSmithKline
4.11.1 GlaxoSmithKline Corporation Information
4.11.2 GlaxoSmithKline Description, Business Overview
4.11.3 GlaxoSmithKline Antibody Products Offered
4.11.4 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2017-2022)
4.11.5 GlaxoSmithKline Antibody Sales by Product in 2021
4.11.6 GlaxoSmithKline Antibody Sales by Application in 2021
4.11.7 GlaxoSmithKline Antibody Sales by Geographic Area in 2021
4.11.8 GlaxoSmithKline Recent Development
4.12 Biogen
4.12.1 Biogen Corporation Information
4.12.2 Biogen Description, Business Overview
4.12.3 Biogen Antibody Products Offered
4.12.4 Biogen Antibody Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Biogen Antibody Sales by Product in 2021
4.12.6 Biogen Antibody Sales by Application in 2021
4.12.7 Biogen Antibody Sales by Geographic Area in 2021
4.12.8 Biogen Recent Development
4.13 AstraZeneca
4.13.1 AstraZeneca Corporation Information
4.13.2 AstraZeneca Description, Business Overview
4.13.3 AstraZeneca Antibody Products Offered
4.13.4 AstraZeneca Antibody Sales, Revenue and Gross Margin (2017-2022)
4.13.5 AstraZeneca Antibody Sales by Product in 2021
4.13.6 AstraZeneca Antibody Sales by Application in 2021
4.13.7 AstraZeneca Antibody Sales by Geographic Area in 2021
4.13.8 AstraZeneca Recent Development
4.14 Sanofi
4.14.1 Sanofi Corporation Information
4.14.2 Sanofi Description, Business Overview
4.14.3 Sanofi Antibody Products Offered
4.14.4 Sanofi Antibody Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Sanofi Antibody Sales by Product in 2021
4.14.6 Sanofi Antibody Sales by Application in 2021
4.14.7 Sanofi Antibody Sales by Geographic Area in 2021
4.14.8 Sanofi Recent Development
4.15 Alexion Pharmaceuticals
4.15.1 Alexion Pharmaceuticals Corporation Information
4.15.2 Alexion Pharmaceuticals Description, Business Overview
4.15.3 Alexion Pharmaceuticals Antibody Products Offered
4.15.4 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Alexion Pharmaceuticals Antibody Sales by Product in 2021
4.15.6 Alexion Pharmaceuticals Antibody Sales by Application in 2021
4.15.7 Alexion Pharmaceuticals Antibody Sales by Geographic Area in 2021
4.15.8 Alexion Pharmaceuticals Recent Development
4.16 Seattle Genetics
4.16.1 Seattle Genetics Corporation Information
4.16.2 Seattle Genetics Description, Business Overview
4.16.3 Seattle Genetics Antibody Products Offered
4.16.4 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Seattle Genetics Antibody Sales by Product in 2021
4.16.6 Seattle Genetics Antibody Sales by Application in 2021
4.16.7 Seattle Genetics Antibody Sales by Geographic Area in 2021
4.16.8 Seattle Genetics Recent Development
5 Breakdown Data by Type
5.1 Global Antibody Sales by Type (2017-2028)
5.1.1 Global Antibody Sales by Type (2017-2022)
5.1.2 Global Antibody Sales Forecast by Type (2023-2028)
5.1.3 Global Antibody Sales Market Share by Type (2017-2028)
5.2 Global Antibody Revenue Forecast by Type (2017-2028)
5.2.1 Global Antibody Revenue by Type (2017-2022)
5.2.2 Global Antibody Revenue Forecast by Type (2023-2028)
5.2.3 Global Antibody Revenue Market Share by Type (2017-2028)
5.3 Antibody Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Antibody Sales by Application (2017-2028)
6.1.1 Global Antibody Sales by Application (2017-2022)
6.1.2 Global Antibody Sales Forecast by Application (2023-2028)
6.1.3 Global Antibody Sales Market Share by Application (2017-2028)
6.2 Global Antibody Revenue Forecast by Application (2017-2028)
6.2.1 Global Antibody Revenue by Application (2017-2022)
6.2.2 Global Antibody Revenue Forecast by Application (2023-2028)
6.2.3 Global Antibody Revenue Market Share by Application (2017-2028)
6.3 Antibody Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Antibody Market Size YoY Growth 2017-2028
7.2 North America Antibody Market Facts & Figures by Country
7.2.1 North America Antibody Sales by Country (2017-2028)
7.2.2 North America Antibody Revenue by Country (2017-2028)
7.3 North America Antibody Sales by Type
7.4 North America Antibody Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Antibody Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Antibody Market Facts & Figures by Region
8.2.1 Asia-Pacific Antibody Sales by Region (2017-2028)
8.2.2 Asia-Pacific Antibody Revenue by Region (2017-2028)
8.3 Asia-Pacific Antibody Sales by Type
8.4 Asia-Pacific Antibody Sales by Application
9 Europe
9.1 Europe Antibody Market Size YoY Growth 2017-2028
9.2 Europe Antibody Market Facts & Figures by Country
9.2.1 Europe Antibody Sales by Country (2017-2028)
9.2.2 Europe Antibody Revenue by Country (2017-2028)
9.3 Europe Antibody Sales by Type
9.4 Europe Antibody Sales by Application
10 Latin America
10.1 Latin America Antibody Market Size YoY Growth 2017-2028
10.2 Latin America Antibody Market Facts & Figures by Country
10.2.1 Latin America Antibody Sales by Country (2017-2028)
10.2.2 Latin America Antibody Revenue by Country (2017-2028)
10.3 Latin America Antibody Sales by Type
10.4 Latin America Antibody Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Antibody Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Antibody Market Facts & Figures by Country
11.2.1 Middle East and Africa Antibody Sales by Country (2017-2028)
11.2.2 Middle East and Africa Antibody Revenue by Country (2017-2028)
11.3 Middle East and Africa Antibody Sales by Type
11.4 Middle East and Africa Antibody Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Antibody Supply Chain Analysis
12.2 Antibody Key Raw Materials and Upstream Suppliers
12.3 Antibody Clients Analysis
12.4 Antibody Sales Channel and Sales Model Analysis
12.4.1 Antibody Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Antibody Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Antibody Distributors
13 Market Dynamics
13.1 Antibody Industry Trends
13.2 Antibody Market Drivers
13.3 Antibody Market Challenges
13.4 Antibody Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Antibody Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of IgM
Table 3. Major Manufacturers of IgG
Table 4. Major Manufacturers of IgA
Table 5. Major Manufacturers of Other
Table 6. Global Antibody Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Antibody Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 8. Global Antibody Sales by Region (2017-2022) & (KG)
Table 9. Global Antibody Sales Forecast by Region (2023-2028) & (KG)
Table 10. Global Antibody Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Antibody Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Antibody Sales by Manufacturer (2017-2022) & (KG)
Table 13. Global Antibody Sales Share by Manufacturer (2017-2022)
Table 14. Antibody Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 15. Antibody Revenue Share by Manufacturer (2017-2022)
Table 16. Key Manufacturers Antibody Price (2017-2022) & (USD/KG)
Table 17. Ranking of Global Top Antibody Manufacturers by Revenue (US$ Million) in 2021
Table 18. Global Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 19. Global Antibody by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibody as of 2021)
Table 20. Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Antibody Product Type
Table 22. Date of International Manufacturers Enter into Antibody Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Roche Corporation Information
Table 25. Roche Description and Business Overview
Table 26. Roche Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 27. Roche Antibody Product
Table 28. Roche Antibody Sales Proportion of Antibody by Product in 2021
Table 29. Roche Antibody Sales Proportion of Antibody by Application in 2021
Table 30. Roche Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 31. Roche Recent Development
Table 32. Johnson and Johnson Corporation Information
Table 33. Johnson and Johnson Description and Business Overview
Table 34. Johnson and Johnson Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 35. Johnson and Johnson Antibody Product
Table 36. Johnson and Johnson Antibody Sales Proportion of Antibody by Product in 2021
Table 37. Johnson and Johnson Antibody Sales Proportion of Antibody by Application in 2021
Table 38. Johnson and Johnson Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 39. Johnson and Johnson Recent Development
Table 40. Merck Corporation Information
Table 41. Merck Description and Business Overview
Table 42. Merck Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 43. Merck Antibody Product
Table 44. Merck Antibody Sales Proportion of Antibody by Product in 2021
Table 45. Merck Antibody Sales Proportion of Antibody by Application in 2021
Table 46. Merck Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 47. Merck Recent Development
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 51. Novartis Antibody Product
Table 52. Novartis Antibody Sales Proportion of Antibody by Product in 2021
Table 53. Novartis Antibody Sales Proportion of Antibody by Application in 2021
Table 54. Novartis Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 55. Novartis Recent Development
Table 56. AbbVie Corporation Information
Table 57. AbbVie Description and Business Overview
Table 58. AbbVie Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 59. AbbVie Antibody Product
Table 60. AbbVie Antibody Sales Proportion of Antibody by Product in 2021
Table 61. AbbVie Antibody Sales Proportion of Antibody by Application in 2021
Table 62. AbbVie Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 63. AbbVie Recent Development
Table 64. Amgen Corporation Information
Table 65. Amgen Description and Business Overview
Table 66. Amgen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 67. Amgen Antibody Product
Table 68. Amgen Antibody Sales Proportion of Antibody by Product in 2021
Table 69. Amgen Antibody Sales Proportion of Antibody by Application in 2021
Table 70. Amgen Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 74. Pfizer Antibody Product
Table 75. Pfizer Antibody Sales Proportion of Antibody by Product in 2021
Table 76. Pfizer Antibody Sales Proportion of Antibody by Application in 2021
Table 77. Pfizer Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 78. Bayer Corporation Information
Table 79. Bayer Description and Business Overview
Table 80. Bayer Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 81. Bayer Antibody Product
Table 82. Bayer Antibody Sales Proportion of Antibody by Product in 2021
Table 83. Bayer Antibody Sales Proportion of Antibody by Application in 2021
Table 84. Bayer Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 85. Lilly Corporation Information
Table 86. Lilly Description and Business Overview
Table 87. Lilly Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 88. Lilly Antibody Product
Table 89. Lilly Antibody Sales Proportion of Antibody by Product in 2021
Table 90. Lilly Antibody Sales Proportion of Antibody by Application in 2021
Table 91. Lilly Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 92. Bristol-Myers Squibb Corporation Information
Table 93. Bristol-Myers Squibb Description and Business Overview
Table 94. Bristol-Myers Squibb Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 95. Bristol-Myers Squibb Antibody Product
Table 96. Bristol-Myers Squibb Antibody Sales Proportion of Antibody by Product in 2021
Table 97. Bristol-Myers Squibb Antibody Sales Proportion of Antibody by Application in 2021
Table 98. Bristol-Myers Squibb Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 99. GlaxoSmithKline Corporation Information
Table 100. GlaxoSmithKline Description and Business Overview
Table 101. GlaxoSmithKline Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 102. GlaxoSmithKline Antibody Product
Table 103. GlaxoSmithKline Antibody Sales Proportion of Antibody by Product in 2021
Table 104. GlaxoSmithKline Antibody Sales Proportion of Antibody by Application in 2021
Table 105. GlaxoSmithKline Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 106. Biogen Corporation Information
Table 107. Biogen Description and Business Overview
Table 108. Biogen Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 109. Biogen Antibody Product
Table 110. Biogen Antibody Sales Proportion of Antibody by Product in 2021
Table 111. Biogen Antibody Sales Proportion of Antibody by Application in 2021
Table 112. Biogen Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 113. AstraZeneca Corporation Information
Table 114. AstraZeneca Description and Business Overview
Table 115. AstraZeneca Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 116. AstraZeneca Antibody Product
Table 117. AstraZeneca Antibody Sales Proportion of Antibody by Product in 2021
Table 118. AstraZeneca Antibody Sales Proportion of Antibody by Application in 2021
Table 119. AstraZeneca Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 123. Sanofi Antibody Product
Table 124. Sanofi Antibody Sales Proportion of Antibody by Product in 2021
Table 125. Sanofi Antibody Sales Proportion of Antibody by Application in 2021
Table 126. Sanofi Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 127. Alexion Pharmaceuticals Corporation Information
Table 128. Alexion Pharmaceuticals Description and Business Overview
Table 129. Alexion Pharmaceuticals Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 130. Alexion Pharmaceuticals Antibody Product
Table 131. Alexion Pharmaceuticals Antibody Sales Proportion of Antibody by Product in 2021
Table 132. Alexion Pharmaceuticals Antibody Sales Proportion of Antibody by Application in 2021
Table 133. Alexion Pharmaceuticals Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 134. Seattle Genetics Corporation Information
Table 135. Seattle Genetics Description and Business Overview
Table 136. Seattle Genetics Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
Table 137. Seattle Genetics Antibody Product
Table 138. Seattle Genetics Antibody Sales Proportion of Antibody by Product in 2021
Table 139. Seattle Genetics Antibody Sales Proportion of Antibody by Application in 2021
Table 140. Seattle Genetics Antibody Sales Proportion of Antibody by Geographic Area in 2021
Table 141. Global Antibody Sales by Type (2017-2022) & (KG)
Table 142. Global Antibody Sales Forecast by Type (2023-2028) & (KG)
Table 143. Global Antibody Revenue by Type (2017-2022) & (US$ Million)
Table 144. Global Antibody Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Antibody Sales by Application (2017-2022) & (KG)
Table 146. Global Antibody Sales Forecast by Application (2023-2028) & (KG)
Table 147. Global Antibody Revenue by Application (2017-2022) & (US$ Million)
Table 148. Global Antibody Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. North America Antibody Sales by Country (2017-2022) & (KG)
Table 150. North America Antibody Sales by Country (2023-2028) & (KG)
Table 151. North America Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 152. North America Antibody Revenue by Country (2023-2028) & (US$ Million)
Table 153. North America Antibody Sales by Type (2017-2022) & (KG)
Table 154. North America Antibody Sales by Application (2017-2022) & (KG)
Table 155. Asia-Pacific Antibody Sales by Region (2017-2022) & (KG)
Table 156. Asia-Pacific Antibody Sales by Region (2023-2028) & (KG)
Table 157. Asia-Pacific Antibody Revenue by Region (2017-2028) & (US$ Million)
Table 158. Asia-Pacific Antibody Revenue by Region (2023-2028) & (US$ Million)
Table 159. Asia-Pacific Antibody Sales by Type (2017-2022) & (KG)
Table 160. Asia-Pacific Antibody Sales by Application (2017-2022) & (KG)
Table 161. Europe Antibody Sales by Country (2017-2022) & (KG)
Table 162. Europe Antibody Sales by Country (2023-2028) & (KG)
Table 163. Europe Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 164. Europe Antibody Revenue by Country (2023-2028) & (US$ Million)
Table 165. Europe Antibody Sales by Type (2017-2022) & (KG)
Table 166. Europe Antibody Sales by Application (2017-2022) & (KG)
Table 167. Latin America Antibody Sales by Country (2017-2022) & (KG)
Table 168. Latin America Antibody Sales by Country (2023-2028) & (KG)
Table 169. Latin America Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 170. Latin America Antibody Revenue by Country (2023-2028) & (US$ Million)
Table 171. Latin America Antibody Sales by Type (2017-2022) & (KG)
Table 172. Latin America Antibody Sales by Application (2017-2022) & (KG)
Table 173. Middle East and Africa Antibody Sales by Country (2017-2022) & (KG)
Table 174. Middle East and Africa Antibody Sales by Country (2023-2028) & (KG)
Table 175. Middle East and Africa Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 176. Middle East and Africa Antibody Revenue by Country (2023-2028) & (US$ Million)
Table 177. Middle East and Africa Antibody Sales by Type (2017-2022) & (KG)
Table 178. Middle East and Africa Antibody Sales by Application (2017-2022) & (KG)
Table 179. Antibody Key Raw Materials, Industry Status and Trend
Table 180. Antibody Key Raw Materials and Upstream Suppliers
Table 181. Antibody Clients Status and Trend
Table 182. Antibody Typical Clients
Table 183. Antibody Distributors
Table 184. Antibody Market Trends
Table 185. Antibody Market Drivers
Table 186. Antibody Market Challenges
Table 187. Antibody Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody Product Picture
Figure 2. Global Antibody Sales Market Share by Type in 2021 & 2028
Figure 3. IgM Product Picture
Figure 4. IgG Product Picture
Figure 5. IgA Product Picture
Figure 6. Other Product Picture
Figure 7. Global Antibody Sales Market Share by Application in 2021 & 2028
Figure 8. Therapeutic Examples
Figure 9. Research Examples
Figure 10. Diagnostic Examples
Figure 11. Antibody Report Years Considered
Figure 12. Global Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Antibody Market Size 2017-2028 (US$ Million)
Figure 14. Global Antibody Sales 2017-2028 (KG)
Figure 15. Global Antibody Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Antibody Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Antibody Revenue Market Share by Region (2017-2028)
Figure 18. Global Antibody Sales Share by Manufacturer in 2021
Figure 19. Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Antibody Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Antibody Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Antibody Average Selling Price (ASP) by Type (2017-2022) & (USD/KG)
Figure 23. Global Antibody Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Antibody Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Antibody Average Selling Price (ASP) by Application (2017-2022) & (USD/KG)
Figure 26. North America Antibody Revenue 2017-2028 (US$ Million)
Figure 27. North America Antibody Sales Market Share by Type (2017-2022)
Figure 28. North America Antibody Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Antibody Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Antibody Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Antibody Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Antibody Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Antibody Sales Market Share by Application (2017-2022)
Figure 34. Europe Antibody Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Antibody Sales Market Share by Country (2017-2028)
Figure 36. Europe Antibody Revenue Market Share by Country (2017-2028)
Figure 37. Europe Antibody Sales Market Share by Type (2017-2022)
Figure 38. Europe Antibody Sales Market Share by Application (2017-2022)
Figure 39. Latin America Antibody Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Antibody Sales Market Share by Country (2017-2028)
Figure 41. Latin America Antibody Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Antibody Sales Market Share by Type (2017-2022)
Figure 43. Latin America Antibody Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Antibody Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Antibody Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Antibody Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Antibody Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Antibody Sales Market Share by Application (2017-2022)
Figure 49. Antibody Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Antibody Raw Materials by Region in 2021
Figure 51. Antibody Distribution Channels
Figure 52. Global Antibody Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Antibody Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs